ninety-seven eligible and evaluable women with metastatic breast cancer were placed on a prospective clinical protocol to evaluate the use of continuous cyclic therapy with dibromodulcitol , doxorubicin , vincristine , tamoxifen , and fluoxymesterone ( davth ) v davth alternating with cyclophosphamide , methotrexate , 5-fluorouracil , and prednisone ( cmfp ) ;
C0016360
5-fluorouracil
C0055985
cmfp